Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain
Clinical trial NCT04466410 · TERMINATED
Trial details
- NCT number
- NCT04466410
- Sponsor
- Xalud Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-09-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.